Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Biphenotypic, Acute × Sunitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 16 Gastrointestinal Stromal Tumors 7 Neoplasms 4 Multiple Myeloma 3 Kidney Neoplasms 3 Urologic Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Kidney Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thoracic Neoplasms 1 Somatostatinoma 1 Solid Tumors Refractory to Standard Therapy 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 1 Pelvic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Nervous System Neoplasms 1

Interventions

fludarabine 18 Cyclophosphamide 18 Whole-Body Irradiation 17 Cytarabine 17 fludarabine phosphate 14 venetoclax 12 Mycophenolic Acid 12 Methotrexate 12 Specimen Handling 10 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 Vincristine 7 Stem Cell Transplantation 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Biopsy 7 Azacitidine 7 merphos 6 blinatumomab 6 Tacrolimus 6 Melphalan 6 Dexamethasone 6 revumenib 5 Idarubicin 5 Hydrocortisone 5 Bone Marrow Transplantation 5 calaspargase pegol 4 Thiotepa 4 Spinal Puncture 4 Prednisone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡